Envoy Medical, Inc. (NASDAQ:COCHW – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totaling 2,168 shares, a drop of 93.3% from the September 15th total of 32,325 shares. Based on an average daily volume of 24,603 shares, the short-interest ratio is presently 0.1 days.
Envoy Medical Price Performance
COCHW stock opened at $0.04 on Friday. The company’s 50-day moving average price is $0.04 and its 200 day moving average price is $0.05. Envoy Medical has a 52 week low of $0.02 and a 52 week high of $0.10.
About Envoy Medical
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technology is designed to be implanted beneath the skin, with the goal of providing hearing support without the external components used by many conventional hearing devices.
Its lead product is the Acclaim cochlear implant, a fully implanted device that uses the body’s natural anatomy to capture sound and stimulate the cochlea. The Acclaim is intended for adults with sensorineural hearing loss and has received Breakthrough Device designation from the U.S.
See Also
- Five stocks we like better than Envoy Medical
- MarketBeat Week in Review – 10/05 – 10/09
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
